Asist Plus

Quick links to important sections

Asist Plus

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Asist Plus

Quick Facts

Property Description
Active ingredient Acetylcysteine (N-acetylcysteine)
Form Granules/Effervescent tablet for oral solution
Pharmacological class Mucolytic Agent, Antidote
Common use Liquefying thick respiratory secretions
Origin Synthetic derivative of L-cysteine

What is the Identity of Asist Plus?

Asist Plus is a pharmaceutical preparation containing the single active ingredient Acetylcysteine, primarily classified as a mucolytic agent. Acetylcysteine (N-acetylcysteine) is recognized globally for its therapeutic utility, appearing on the World Health Organization’s List of Essential Medicines. The drug is classified as a mucolytic, whose main action is to modify the physical consistency of mucus. Acetylcysteine also holds a critical secondary classification as a specific antidote, clinically recognized for its use in the management of acetaminophen (Paracetamol) overdose.

Composition, Form, and Origin (Acetylcysteine)

The active substance, Acetylcysteine, is a synthetic N-acetyl derivative of the naturally occurring amino acid L-cysteine. This chemical structure, featuring a free sulfhydryl group, is fundamental to its chemical mechanism of action. Asist Plus is formulated for oral administration and is typically supplied in forms that dissolve readily, such as the single-dose sachet containing granules for oral solution or an effervescent tablet. These presentations are designed to simplify the delivery of the substance through an aqueous vehicle (water) after reconstitution.

What is the General Therapeutic Purpose of a Mucolytic Agent?

The general purpose of a mucolytic agent is to address conditions involving abnormally thick, viscous secretions in the lungs and airways. Acetylcysteine achieves this through mucolysis, where it chemically breaks the disulfide bonds in the mucoproteins that make mucus dense. By reducing the mucus's viscosity, the drug facilitates the body's natural processes of expectoration (clearing) of secretions from the respiratory tract. A mucolytic agent helps the patient more effectively manage heavy chest congestion by supporting the body’s natural clearance mechanisms.

What side effects are possible with Asist Plus?

Possible Side Effects and Safety Information

The information below on the adverse effects and safety characteristics of oral Acetylcysteine (the active ingredient in Asist Plus) is based exclusively on official government regulatory documents.


Official Adverse Reactions and Frequency

Adverse effects are categorized by the body system affected (System-Organ Class or SOC) and their documented frequency of occurrence, according to regulatory standards (e.g., EMA SmPC terminology).

System-Organ Class (SOC) Frequency Category Adverse Reaction
Gastrointestinal Disorders Uncommon Vomiting, Diarrhoea, Nausea, Abdominal pain, Stomatitis
Immune System Disorders Uncommon Hypersensitivity
Very Rare Anaphylactic shock, Anaphylactoid reaction
Skin and Subcutaneous Tissue Disorders Uncommon Urticaria, Rash, Pruritus
Very Rare Stevens-Johnson syndrome, Toxic Epidermal Necrolysis
Respiratory Disorders Rare Bronchospasm, Dyspnoea
General/Other Uncommon Headache, Tinnitus, Pyrexia (fever)

Safety Considerations and Constraints

Regulatory documents include specific constraints and monitoring requirements for certain individuals:

  • Patients with Bronchial Asthma: Close monitoring is required. If bronchospasm occurs, treatment must be discontinued immediately.
  • Pregnancy and Lactation: Use during pregnancy is generally advised to be avoided as a precautionary measure. It is unknown if the substance is excreted in human milk.
  • Peptic Ulcer History: Caution is advised for patients with a history of peptic ulcer, particularly when other gastric irritants are used concurrently.
  • Treatment Initiation: The liquefaction of secretions at the beginning of treatment may increase their volume, which may require monitoring.

Serious Adverse Reactions: The label documents rare but serious reactions, including anaphylactic shock and severe skin conditions like Stevens-Johnson syndrome, which necessitate immediate discontinuation.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that an overdose of Acetylcysteine (the active ingredient in Asist Plus) requires immediate professional attention.


Documented Overdose Manifestations

An acute, excessive dose may initially result in gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and abdominal pain. Regulatory documents also cite the potential for more severe systemic outcomes, including haemolysis (red blood cell destruction), acute renal failure, acidosis, and generalized seizure.

Required Emergency Actions

Seek immediate medical attention or contact the nearest hospital emergency department immediately if an overdose is suspected or has occurred. Treatment is formally described as symptomatic and supportive, as there is no specific antidote for Acetylcysteine overdose. Supportive procedures, such as ensuring airways are kept clear of secretions or performing gastric lavage within 30 minutes of ingestion, are guided by clinical assessment.


Population-Specific Considerations

Official labeling contains specific warnings for children and patients weighing less than 40 kg. In this population, administration may carry an increased risk of fluid overload, which can result in hyponatraemia (low sodium) and subsequent seizures that may be life-threatening.

Therapeutic Uses of Asist Plus

What Asist Plus Treats: Main Uses and Benefits

Asist Plus is commonly used across two distinct therapeutic domains, primarily addressing symptoms related to physical discomfort from retained secretions and providing critical support in a specific toxicological context. In respiratory medicine, it is applied in addressing symptoms of thick, tenacious phlegm in conditions characterized by periods of heightened symptoms like Chronic Obive Pulmonary Disease (COPD), chronic bronchitis, and Cystic Fibrosis. Its use in these situations supports the liquefaction of secretions, which may help the patient cope more steadily with symptom fluctuations. This contributes to improved respiratory comfort and assists with maintaining functional stability during symptomatic periods.

The medication's secondary, yet critical, use is as an antidote following acute, high-dose ingestion of acetaminophen (Paracetamol). This intervention is considered relevant when short-term symptomatic assistance is needed to mitigate the toxic effects of the overdose. This use is essential for providing therapeutic support to the liver, helping to prevent or lessen the development of severe, acute liver injury.


Quick Fact: Relief for Congested Airways
Primary Use Focus Conditions with highly viscous, retained respiratory mucus
Symptom Relieved Difficulty coughing up thick, sticky phlegm
Benefit for Patient Contributes to improved comfort by easing expectoration
Critical Secondary Role Antidote for acute acetaminophen toxicity

Regulatory References

  1. MedlinePlus Drug Information on Acetylcysteine

Eligibility and Restrictions for Use

Asist Plus is generally prescribed for individuals diagnosed with specific respiratory conditions characterized by excessive, thick mucus. The decision to use this medication is based on a comprehensive assessment of the patient's medical history and current health status.


Who Can Use Asist Plus?

Patient Group Indication Summary
Adults and Adolescents Treatment of respiratory tract diseases with abnormal, tenacious, or excessive mucus secretions.
Children (Aged 2 years and above) May be used in certain pediatric cases under strict medical supervision and appropriate dosing.

Contraindications (Who Should Not Use Asist Plus?)

Asist Plus is contraindicated in certain patient groups to prevent adverse effects. It should not be used in cases of known hypersensitivity or allergy to the active ingredient or any of the excipients in the formulation.

Caution is also advised, and use is generally avoided, in the following situations:

  • Patients with an active peptic ulcer or a history of recurrent ulcer disease, as it may increase the risk of gastrointestinal bleeding.
  • Individuals with severe bronchial asthma, as the medication may potentially worsen bronchospasm in some sensitive individuals.
  • Infants under 2 years of age, due to the potential for increasing airway obstruction.

Patients should always inform their healthcare provider about all pre-existing medical conditions before starting treatment with Asist Plus.

What should I know about interactions with other medicines?

The official regulatory profile for Acetylcysteine (Asist Plus) details mandated restrictions and specific interaction outcomes with other medicines, products, and diagnostic tests.

Prohibited and Pharmacodynamic Interactions

Co-administration with antitussive medicinal products is prohibited. This restriction stems from a documented pharmacodynamic interaction where the suppression of the cough reflex, combined with the action of Acetylcysteine, may lead to the accumulation of bronchial secretions.

When co-administered with Nitroglycerin (organic nitrates), a clinically significant interaction is documented, causing significant hypotension and temporal artery dilation, which may result in a headache.

Chemical Inactivation and Timing Rules

The product's effectiveness can be reduced by certain substances. Activated charcoal may decrease the therapeutic effect of Acetylcysteine through physical adsorption.

A mandatory timing rule is also specified for co-administration with oral antibiotics. Due to in vitro evidence of potential antibiotic inactivation, the administration of these products must be separated by at least two hours.

Diagnostic Interference and Risk Modifiers

Acetylcysteine is documented to interfere with certain laboratory tests, specifically the colorimetric assay method for the determination of salicylates and standard tests for ketones in urine.

Furthermore, the official labeling notes that factors such as chronic alcoholism, malnutrition, or the presence of CYP2E1 enzyme-inducing drugs may alter risk assessments in the context of its secondary role as an antidote.

Mechanism of Action

The mechanism of Acetylcysteine involves two distinct, primary domains of action: a chemical modification of biopolymers and a metabolic augmentation of a core defense system. This dual mechanism contributes to the molecule's distinct physiological actions.


Chemically Modifying Secretion Viscoelasticity

This domain covers the direct interaction of the drug with the physical structure of mucosal secretions. Acetylcysteine's free sulfhydryl group ( -SH) acts as a reducing agent, directly cleaving the disulfide bonds ( S-S) linking the large mucoprotein chains. The resulting breakdown of the mucin matrix lowers the viscosity and elasticity of secretions, enabling increased mucociliary transport.


️ Augmenting the Cellular Antioxidant Pathway

The second domain involves augmenting the cell's inherent mechanism for managing chemical stress. As a precursor to L-cysteine, the drug enhances the intracellular biosynthesis of glutathione (GSH), the central molecule in cellular defense against oxidative stress. This metabolic enhancement increases the cell's capacity to neutralize highly reactive chemical intermediates like NAPQI, contributing to the maintenance of cellular structure during chemical insult.

Dosage and Administration Information

The use of Asist Plus (Acetylcysteine) follows two distinct protocols, differentiating its administration for mucolytic purposes and its function as an antidote.


Administration Scope

Feature Mucolytic Use (Oral / Inhalation) Antidote Use (Intravenous)
Route of Administration Oral (solution) or Inhalation (nebulizer) Intravenous (IV) Infusion only
Dosing Schedule 200 mg per dose, three times a day for adults/adolescents over 12 years. Total cumulative dose of 300 mg/kg administered across three sequential infusions.
Preparation Requirements Granules must be dissolved completely in a small amount of water and consumed immediately; solution must not be mixed with other medicinal products. The concentrated solution must be diluted in compatible IV fluid prior to administration; not for direct injection.
Frequency and Schedule Typically administered three times per day. Administered over a fixed 21-hour course consisting of three separate timed infusions (1-hour, 4-hour, and 16-hour periods).
Age-Group Rules The 200 mg sachet is not suitable for children under 12 years of age. Dosing is strictly weight-based (mg/kg), and fluid volume must be adjusted for patients under 40 kg.

Connection to the Overall Use Protocol

These instructions establish that the use of Acetylcysteine is governed by a rigid distinction: a repetitive, multiple-times-daily oral regimen for mucolytic support, versus a formalized, time-critical sequence of infusions for its antidote application. This dual structure ensures adherence to the specific dose, route, and timing required for each application.

Recent Clinical Evidence

Asist Plus: Recent Clinical Evidence

This section summarizes key research that has explored the development and evaluated the outcomes of Asist Plus. The information is strictly descriptive of study findings and is not intended as medical advice or interpretation of therapeutic suitability.

Monotherapy Study

Research regarding Asist Plus as a single agent involved a randomized, double-blind, placebo-controlled trial. The study enrolled 450 adult participants diagnosed with moderate-to-severe chronic pain and had a duration of 12 weeks. One study assessed the effect of Asist Plus on pain scores relative to the control group. The trial measured patient-reported pain scores at the 12-week endpoint. Research also evaluated whether administration of the drug was associated with a measured difference in inflammation in participants.

Combination Therapy

Studies have also explored the use of Asist Plus in combination with a standard monotherapy. Research evaluated changes in symptoms when the combination therapy was administered compared with the standard single-agent treatment. Further studies evaluated the potential analgesic effect, measuring the time to symptom change relative to a placebo. Continuous research is exploring the drug's potential role in long-term disease management, ensuring a comprehensive understanding of its profile.

Frequently Asked Questions (FAQ)

Common questions about Asist Plus (FAQ)


Q: How quickly does Asist Plus start working after taking it?

Studies on the active ingredient indicate that peak concentrations in the bloodstream are typically reached relatively quickly, usually within 1 to 2 hours following oral administration. This time frame indicates when the highest level of the active ingredient is generally present in the bloodstream.


Q: What is the longest period of time people typically take Asist Plus?

Official regulatory documents do not specify a maximum duration for the drug’s mucolytic use. The duration of therapy is highly dependent on the individual's chronic medical condition and is determined by a healthcare provider. The official label outlines a fixed, short-term 21-hour course only when the drug is used in its critical secondary role as an antidote.


Q: Does Asist Plus interact with common over-the-counter pain relievers?

Official regulatory labeling does not describe known interactions with all common over-the-counter pain relievers. Official product information states that administration must be separated from oral antibiotics by at least two hours. A significant interaction that may cause a drop in blood pressure is documented when this medicine is co-administered with Nitroglycerin.


Q: What happens if I accidentally take two doses of Asist Plus close together?

The regulatory label provides specific dosing schedules but does not offer a standard protocol for taking a double dose for mucolytic use. Reports of excessive dosing have noted adverse effects such as nausea, vomiting, bronchospasm, and hypotension.


Q: Does Asist Plus affect blood pressure or heart rate?

The official side effect profile for the drug when taken alone does not commonly list direct changes to heart rate or blood pressure. However, regulatory documents state that a significant drop in blood pressure (hypotension) is documented when it is co-administered with Nitroglycerin.


Q: Can Asist Plus be taken by pregnant women or those planning pregnancy?

Use of the product during pregnancy is generally advised to be avoided as a precautionary measure, due to the limited data available on human use. Furthermore, official information states that it is currently unknown if the substance is excreted in human milk during lactation.


Q: Why do some people feel sleepy when they start taking Asist Plus?

Drowsiness or sleepiness is not explicitly listed as a common or uncommon side effect in the official adverse reactions list for the oral formulation. Uncommon systemic effects that are listed include headache, ringing in the ears (tinnitus), and fever (pyrexia).


Q: Can Asist Plus be taken by people with kidney issues?

Caution is advised for patients who have pre-existing kidney or heart conditions, as the formulation contains sodium which may worsen these issues. Additionally, the antidote form of the drug requires strict adjustment of fluid volume for smaller patients.


Q: Is it necessary to avoid alcohol completely while using Asist Plus?

Official warnings do not specify a blanket requirement for complete avoidance of alcohol consumption. However, official labeling advises that chronic alcoholism may be a factor that alters risk assessments related to liver health in the context of the drug’s antidote use.


Q: Has Asist Plus been studied in children or adolescents?

Yes. The drug is officially indicated for use in adolescents and children aged 2 years and above for managing specific respiratory tract diseases, which indicates that studies were conducted to establish its use and dosing rules for these age groups.


Q: What is the chemical name of the active ingredient in Asist Plus?

The active ingredient, Acetylcysteine, is chemically known as N-acetylcysteine. This substance is a synthetic derivative of the naturally occurring amino acid L-cysteine.


Q: Does Asist Plus require a special prescription or monitoring?

The product is officially designated as a prescription-only medication. Close monitoring by a healthcare provider is specifically required for individuals with bronchial asthma. When used as an antidote, official documents mandate extensive laboratory monitoring.


Q: Is the medication Asist Plus known to affect liver function?

The drug is intrinsically linked to liver function: its secondary, critical use is as an antidote to prevent or lessen hepatic (liver) injury following an overdose of acetaminophen. Its mechanism works by augmenting the cellular antioxidant pathway. Pharmacokinetics may also be altered in patients with chronic liver disease.


Q: Do studies suggest Asist Plus is more suitable for certain patients than others?

Official regulatory documents define specific suitability constraints by identifying individuals with severe bronchial asthma or an active peptic ulcer as patient groups for whom caution or contraindication is advised.

How should Asist Plus be stored and disposed of?

How to Store and Dispose of Asist Plus

The storage of Asist Plus (Acetylcysteine granules) is determined by its formulation, with distinct rules for the unopened product and the prepared solution.

Storage Requirements

The unopened granules must be stored at a temperature not exceeding 30 C. The product must remain protected from light and moisture by being kept in its original package.

For the reconstituted solution, official labeling typically requires the product to be administered immediately. If permitted by a specific label, the solution must be stored in a refrigerator at 2 C to 8 C for a maximum of 12 days. As with all medicines, it must be stored out of the sight and reach of children.

Disposal Instructions

Official regulatory documents state that unused or expired Asist Plus must not be thrown away via wastewater or household waste. Disposal must follow procedures set by the local authority or pharmacist in accordance with pharmaceutical waste requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Asist Plus found in:

A-Z Index: